Evidence has been accumulating in support of RNASEL as a prostate cancer risk locus, with several recent large case–control and cohort studies and a very large meta-analysis all showing significant associations of prostate cancer risk with polymorphisms in this locus[6-10]. The gene discussed is RNASEL; the disease is prostate carcinoma.